Merit Medical Buys Remaining Solo Pace Equity for About $45M
Merit Medical bought all remaining outstanding equity of Solo Pace for about $45 million.
Related stories
Anthropic Plans $62.5 Billion IPO for Next Week
Anthropic wants to raise $62.5 billion in a public offering next week. The source asks whether the IPO could affect the broader U.S. equity market.
M impact | MNA | Nov 15, 2026, 02:00 PM UTC
Novelis Agrees to Sell Two China Units for $265 Million
Hindalco said its US-based subsidiary Novelis agreed to sell two Chinese subsidiaries for about $265 million. The proposed sale includes the subsidiary operating Novelis's automoti
M impact | MNA | Nov 15, 2026, 11:55 AM UTC
Novelis Agrees to Sell Its China Aluminum Subsidiaries
M impact | MNA | Nov 15, 2026, 05:39 AM UTC
Hindalco's Novelis Agrees to Sell China Aluminum Subsidiaries
M impact | MNA | Nov 15, 2026, 05:37 AM UTC
Centrica and Equinor Advance to Next Round of Uniper Sale
Centrica and Equinor are in the next round of Germany’s Uniper sale, Bloomberg News reports.
M impact | MNA | Nov 14, 2026, 10:23 AM UTC
Pricol Promoters to Sell 38.51% Stake in Autotech Unit to Warburg Pincus
Pricol said its board approved the sale of promoters’ entire 38.51% shareholding in Pricol Autotech Limited to Warburg Pincus.
M impact | MNA | Nov 14, 2026, 02:29 AM UTC